Improving access to sight loss certification among glaucoma patients

Published on May 13, 2025
UK and Australian clinicians have described the use of semi-automated screening technology that assesses CVI eligibility
Continue reading on website
Other news

Potentially hazardous eye care products recalled nationwide

May 12, 2025
BRS Analytical Service, LLC, an independent contract testing laboratory, initiated the recall because of possible concerns about product quality and safety linked to the manufacturing process. An FDA audit revealed serious manufacturing violations of Current Good Manufacturing Practice.

Reserpine has potential to be repurposed as treatment for retinitis pigmentosa, studies suggest

May 13, 2025
The drug was previously approved for high blood pressure in 1955.